Oslo Cancer Cluster
Cancer Crosslinks 2019
Test
Next Wave of Precision Oncology for Patients in Norway
Panel Debate
Implementing Precision Medicine in the UK - Status, Lessons Learned and the Way Forward
James Peach
Hematological Cancers – Emerging Treatment Opportunities and the Impact of Big Data
Lars Bullinger
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
Marco Gerlinger
Immunophenotypes: The T cell-inflamed Tumor Microenvironment as a Biomarker and its Clinical Implications
Randy F. Sweis
Clinical Aspects of Tumour Mutational Burden and other Tissue Agnostic Biomarkers for Cancer Immunotherapy
Aaron Goodman
Sensitivity and Resistance to I-O: Biological Insights and their Translation into Precision Treatment
Naiyer Rizvi